Dr. Martin I. Meltzer is a Senior Advisor and a Distinguished Consultant in the National Center for Emerging and Zoonotic Infectious Diseases (NCEZID/CDC) in Atlanta, GA.  He received his undergraduate degree from the University of Zimbabwe in 1982, and a Masters and a Doctorate in Applied Economics from Cornell University, NY, in 1987 and 1990, respectively. From 1990 to mid-1995, he was on the faculty at the College of Veterinary Medicine at the University of Florida. In 1995, he moved to the CDC, where his research has included estimating the impact of the 2009 influenza pandemic, the modeling of potential responses to smallpox outbreaks and assessing the economics of controlling diseases such as rabies, dengue, hepatitis A, meningitis, Lyme, and malaria. He also led modeling teams supporting the CDC’s emergency responses to the 2009 H1N1 influenza pandemic, the 2012 contaminated steroid injectable products, Ebola outbreaks in West Africa (2014-16) and the Democratic Republic of the Congo (2018-19), the Zika epidemic, the COVID Response, the 2022 Ebola outbreak in Uganda, and the 2022 Mpox epidemic. Dr. Meltzer has over 300 publications and has worked on more than 60 software tools, including FluAid, FluSurge and FluWorkLoss, COVIDSurge, COVIDTracer, and COVIDTracer Advanced. In 2022, he also led the team that developed the COVID Quarantine and Isolation Calculator, with approximately 14 million unique visitors. He is an associate editor for Emerging Infectious Diseases.